Table 1:
Gender | Male | 1 (4.8%) |
Female | 20 (95.2%) | |
Race | African American | 5 (23.8%) |
Asian | 2 (9.5%) | |
White | 14 (66.7%) | |
Age at interview | ≥59 | 8 (38.1%) |
40–59 | 11 (52.4%) | |
≤39 | 2 (9.5%) | |
Personal history if cancer | No | 5 (23.8%) |
Yes a | 16 (76.2%) | |
Breast | 12 (75.0%) | |
Colon | 1 (6.3%) | |
Leukemia | 1 (6.3%) | |
Lung | 1 (6.3%) | |
Lymphoma | 1 (6.3%) | |
Renal | 1 (6.3%) | |
Sarcoma | 1 (6.3%) | |
Skin | 2 (12.5%) | |
Thyroid | 2 (12.5%) | |
Family history of cancer | No | 1 (4.8%) |
Yes a | 20 (95.2%) | |
Breast | 15 (75.0%) | |
Other | 18 (90.0%) | |
Number of years between offer of testing and interview | 1 | 4 |
2 | 5 | |
3 | 4 | |
4 | 5 | |
5 | 3 |
Some participants have had multiple cancers and had family members with multiple forms of cancer. Therefore these numbers will not total 100%.